FDA Drug recall D-0969-2015
0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02
- FDA Drug
- Class I
- terminated
- Published 2015-04-29
On 2015-04-29 the FDA classified a Class I recall of 0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02 by Hospira, citing presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0969-2015 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2015-01-20 |
| Published | 2015-04-29 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02
Reason
Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.
Identifiers
| code_info | Lot #: 44-002-JT (the lot number may be followed by 01 to 99), Exp 08/01/2016 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0969-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.